BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 38555229)

  • 1. Reply to: Comment on "Management of 80 sinonasal undifferentiated carcinomas. Retrospective multicentre study of the French Network of Rare Head and Neck Cancers (REFCOR). https://doi. org/ 10.1016/j.ejso.2023.107108.".
    Dupin C;
    Eur J Surg Oncol; 2024 Jun; 50(6):108268. PubMed ID: 38555229
    [No Abstract]   [Full Text] [Related]  

  • 2. Comment on "Management of 80 sinonasal undifferentiated carcinomas. Retrospective multicentre study of the French Network of Rare Head and Neck Cancers (REFCOR). https://doi.org/10.1016/j.ejso.2023.107108.".
    Topkan E; Somay E; Selek U
    Eur J Surg Oncol; 2024 Jun; 50(6):108267. PubMed ID: 38521642
    [No Abstract]   [Full Text] [Related]  

  • 3. Management of 80 sinonasal undifferentiated carcinomas. Retrospective multicentre study of the French Network of Rare Head and Neck Cancers (REFCOR).
    Pouvreau P; Coelho J; Rumeau C; Malard O; Garrel R; Michel J; Righini C; Vergez S; Baudouin R; Bastit V; Marie JP; Villepelet A; Moya-Plana A; Philouze P; Saroul N; Digue L; Daste A; Renard S; Moriniere S; Carsuzaa F; Verillaud B; Poissonnet G; Schultz P; Brenet E; Mouawad F; Thariat J; Vulquin N; Castain C; de Gabory L; Dupin C
    Eur J Surg Oncol; 2023 Dec; 49(12):107108. PubMed ID: 37866154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved clinical outcomes with multi-modality therapy for sinonasal undifferentiated carcinoma of the head and neck.
    Yoshida E; Aouad R; Fragoso R; Farwell DG; Gandour-Edwards R; Donald PJ; Chen AM
    Am J Otolaryngol; 2013; 34(6):658-63. PubMed ID: 23993024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival Outcomes for Combined Modality Therapy for Sinonasal Undifferentiated Carcinoma.
    Kuo P; Manes RP; Schwam ZG; Judson BL
    Otolaryngol Head Neck Surg; 2017 Jan; 156(1):132-136. PubMed ID: 27703092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of olfactory neuroblastoma, neuroendocrine carcinoma, and sinonasal undifferentiated carcinoma involving the skullbase.
    Mehta GU; Raza SM; Su SY; Hanna EY; DeMonte F
    J Neurooncol; 2020 Dec; 150(3):367-375. PubMed ID: 32424573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meta-analysis of 701 published cases of sinonasal neuroendocrine carcinoma: The importance of differentiation grade in determining treatment strategy.
    van der Laan TP; Iepsma R; Witjes MJ; van der Laan BF; Plaat BE; Halmos GB
    Oral Oncol; 2016 Dec; 63():1-9. PubMed ID: 27938993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of nonesthesioneuroblastoma sinonasal malignancies with neuroendocrine differentiation.
    Fried D; Zanation AM; Huang B; Hayes N; Morris DE; Rosenman J; Varia M; Funkhouser W; Weissler M; Chera BS
    Laryngoscope; 2012 Oct; 122(10):2210-5. PubMed ID: 22886723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sinonasal undifferentiated carcinoma: morphological heterogeneity, diagnosis, management and biological markers.
    Bell D; Hanna EY
    Expert Rev Anticancer Ther; 2013 Mar; 13(3):285-96. PubMed ID: 23477516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncologic management of sinonasal undifferentiated carcinoma.
    Tyler MA; Holmes B; Patel ZM
    Curr Opin Otolaryngol Head Neck Surg; 2019 Feb; 27(1):59-66. PubMed ID: 30507692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting
    Robinson H; Green M; Radkar G; Ready N; Strickler J
    Cancer Invest; 2021 Mar; 39(3):235-239. PubMed ID: 33538211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical characteristics and prognostic factors of sinonasal undifferentiated carcinoma: a multicenter study.
    de Bonnecaze G; Verillaud B; Chaltiel L; Fierens S; Chapelier M; Rumeau C; Malard O; Gavid M; Dufour X; Righini C; Uro-Coste E; Rives M; Bach C; Baujat B; Janot F; de Gabory L; Vergez S
    Int Forum Allergy Rhinol; 2018 Sep; 8(9):1065-1072. PubMed ID: 29935059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SMARCB1 (INI-1)-deficient Sinonasal Carcinoma: A Series of 39 Cases Expanding the Morphologic and Clinicopathologic Spectrum of a Recently Described Entity.
    Agaimy A; Hartmann A; Antonescu CR; Chiosea SI; El-Mofty SK; Geddert H; Iro H; Lewis JS; Märkl B; Mills SE; Riener MO; Robertson T; Sandison A; Semrau S; Simpson RH; Stelow E; Westra WH; Bishop JA
    Am J Surg Pathol; 2017 Apr; 41(4):458-471. PubMed ID: 28291122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trimodality management of sinonasal undifferentiated carcinoma and review of the literature.
    Mourad WF; Hauerstock D; Shourbaji RA; Hu KS; Culliney B; Li Z; Jacobson A; Tran T; Manolidis S; Schantz S; Urken M; Persky M; Harrison LB
    Am J Clin Oncol; 2013 Dec; 36(6):584-8. PubMed ID: 22992621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Rare cancers of the head and neck on behalf of the REFCOR, part 1].
    Chabrillac E; Even C; Costes-Martineau V; Fakhry N; Digue L; Moya-Plana A; Baujat B; Righini CA; De Gabory L; Verillaud B; Vergez S; Thariat J;
    Bull Cancer; 2023 Jun; 110(6):692-699. PubMed ID: 37169603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes and patterns of failure for sinonasal undifferentiated carcinoma (SNUC): The Mayo Clinic Experience.
    Gamez ME; Lal D; Halyard MY; Wong WW; Vargas C; Ma D; Ko SJ; Foote RL; Patel SH
    Head Neck; 2017 Sep; 39(9):1819-1824. PubMed ID: 28561906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IDH2 Mutation Analysis in Undifferentiated and Poorly Differentiated Sinonasal Carcinomas for Diagnosis and Clinical Management.
    Riobello C; López-Hernández A; Cabal VN; García-Marín R; Suárez-Fernández L; Sánchez-Fernández P; Vivanco B; Blanco V; López F; Franchi A; Llorente JL; Hermsen MA
    Am J Surg Pathol; 2020 Mar; 44(3):396-405. PubMed ID: 31876581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NUT midline carcinomas of the sinonasal tract.
    Bishop JA; Westra WH
    Am J Surg Pathol; 2012 Aug; 36(8):1216-21. PubMed ID: 22534723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical management of localized undifferentiated sinonasal carcinoma: our experience and review of the literature.
    Perri F; Della Vittoria Scarpati G; Ionna F; Longo F; Montano M; Muto P; Ravo V; Giuliano M; Caponigro F
    Anticancer Drugs; 2019 Mar; 30(3):308-312. PubMed ID: 30779722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leptomeningeal carcinomatosis in sinonasal undifferentiated carcinoma.
    Liu SV; Wagle N; Zada G; Sun B; Go J; Rashtian A
    Head Neck; 2013 Nov; 35(11):E343-5. PubMed ID: 23471826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.